Article Details
Retrieved on: 2021-09-01 13:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
1, 2021 /PRNewswire/ -- Statera BioPharma (NASDAQ: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here